CaMKII inhibition protects against necrosis and apoptosis in irreversible ischemia-reperfusion injury by Vila Petroff, Martín Gerardo et al.
Cardiovascular
Research
ELSEVIER Cardiovascular Research 73 (2007) 689-698
www.elsevier.com/locate/cardiores
CaMKII inhibition protects against necrosis and apoptosis in irreversible 
ischemia-reperfusion injury
Martin Vila-Petroff al, Margarita A. Salas a>1, Matilde Saida, Carlos A. Valverde a, 
Luciana Sapiaa, Enrique Portianskyb, Roger J. Hajjarc. Evangelia G. Kraniasd, 
Cecilia Mundiña-Weilenmann a *„ Alicia Mattiazzia’*
a Centro de Investigaciones Cardiovasculares, Facultad de Ciencias Médicas, 60 y 120, (1900) La Plata. Argentina
h Departamento de Patología, Facultad de Veterinaria, La Plata, Argentina
c Cardiovascular Research Center, Massachusetts General Hospital, Charlestown, MA 02129, USA 
d Department of Pharmacology and Cell Biophysics. University of Cincinnati College of Medicine, Cincinnati, OH 45267-0575, USA
Received 1 September 2006; received in revised form 14 November 2006; accepted 4 December 2006
Available online 15 December 2006
Time for primary review 35 days
Abstract
Objectives: Ca2+/calmodulin-dependent protein kinase 11 (CaMKII) has been implicated in the regulation of cardiac excitation-contraction 
coupling (ECC) as well as in apoptotic signaling and adverse remodeling. The goal of the present study is to investigate the role of CaMKII 
in irreversible ischemia and reperfusion (1/R) injury.
Methods: Isovolumic Langendorff perfused rat hearts were subjected to global no-flow I/R (45 min/120 min), and isolated myocytes were 
subjected to a protocol of simulated I/R (45 min simulated ischemia/60 min reoxygenation) either in the absence or presence of CaMKII 
inhibition [KN-93 (KN) or the CaMKII inhibitory peptide (AIP)].
Results: In I/R hearts, an increase in CaMKII activity at the beginning of reperfusion was confirmed by the significantly increased phosphorylation 
of the Thr17 site ofphospholamban. In the presence of KN, contractile recovery at the end of reperfusion was almost double that of I/R hearts. This 
recovery was associated with a significant decrease in the extent of infarction, lactate dehydrogenase release (necrosis), TUNEL-positive cells, 
caspase-3 activity, and an increase in the Bcl-2/Bax ratio (apoptosis). In isolated myocytes, both KN and AIP prevented simulated I/R-induced 
spontaneous contractile activity and cell mortality. Similar results were obtained when inhibiting the reverse mode Na /Ca2 exchanger (NCX) with 
KB-R7943, sarcoplasmic reticulum (SR) function with ryanodine and thapsigargin, or SR Ca2+ release with tetracaine. In contrast, overexpression 
of CaMKII decreased cell viability from 52±3% to 26±2%.
Conclusions: Taken together, the present findings are the first to establish CaMKII as a fundamental component of a cascade of events 
integrating the NCX, the SR, and mitochondria that promote cellular apoptosis and necrosis in irreversible I/R injury.
© 2006 European Society of Cardiology. Published by Elsevier B.V. All rights reserved.
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1. Introduction
Coronary ischemic disease is one of the most important 
causes of adult mortality in Western countries. This reflects the 
lack of effective therapies targeted to the molecular basis of
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ischemia/reperfusion (I/R) damage and is the main trigger for 
the enormous effort focused on elucidating the basic biological 
processes within the ischemic myocardium. In the past few 
years evidence has grown indicating that modification of 
reperfusion conditions is critical for reducing the damage to the 
ischemic heart. It was shown that the early phase of reperfusion 
is of particular relevance because cardiac injury (reperfusion 
injury’) may occur in this phase, in addition to the injury 
produced by the preceding ischemia [1]. Reperfusion injury 
appears, however, to be a complex phenomenon, and its
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underlying mechanisms are still unclear [2-5]. Recent 
experiments from our laboratory described for the first time a 
cascade of events that involves enhanced Ca2+ influx, CaMKll 
activation and phosphorylation of phospholamban (PLN) at 
the Thr17 residue that is beneficial for the recovery of con­
tractility and intracellular Ca2+(Ca2+) handling in reversible 1/ 
R injury, also known as stunned heart [6-8]. The protective 
effects of the phosphorylation of PLN residues in the stunned 
heart are also supported by experiments in which the phos­
phorylation of Ser16 of PLN by PKG increased the contractile 
recovery of isolated myocytes submitted to simulated I/R [9].
CaMKIIô is the predominant CaMKll isoform in the heart, 
and its splice variant ôc resides in the cytosol. In addition to its 
well documented role in the regulation of cardiac excitation- 
contraction-coupling [10-12], CaMKIIôc has been implicated 
in apoptotic signaling [13-16] and in mediating the transition 
to heart failure [17]. These latter reports, together with recent 
evidence indicating that both necrosis and apoptosis cause 
cardiac injury during 1/R, could suggest a detrimental role of 
CaMKll-dependent phosphorylations that may contribute to 
the irreversible 1/R injury. These results are in clear contrast to 
the beneficial effect previously described for reversible 1/R 
injury [6-8]. The present experiments were undertaken to 
explore whether CaMKll activity is either protective or 
detrimental in irreversible 1/R disease, and in the last case, 
whether CaMKll increases cardiac injury by favoring necrosis 
and/or promoting apoptosis.
2. Methods
2.1. Animals
Wistar male rats (200-300 g) were anaesthetised by intra­
abdominal injection of sodium pentobarbitone (35 mg (kg 
body weight) 1 ). Animals used in this study were maintained 
in accordance with the Guide for the Care and Use of Lab­
oratory Animals (N1H Pubheation No. 85-23, revised 1996).
2.2. Langendorff perfusion
Isolated hearts were perfused according to the Langendorff 
technique at constant temperature (37 °C), coronary flow (12- 
14 ml/min) and heart rate (240 beats/min), as previously 
described [6,7]. The mechanical activity of the heart was 
assessed by passing into the left ventricle (LV) a latex balloon 
connected to a pressure transducer (ADInstruments MLT95 80, 
CO) and filled with aqueous solution to achieve a left ventricu­
lar end-diastolic pressure of approximately 10 mm Hg. LV 
contractility was evaluated by the developed pressure (LVDP ) 
and the maximal rate of pressure development (+dP/dt).
2.3. Experimental protocol
After stabilization, hearts were perfused for 10 min and then, 
normothermic global ischemia was produced by interruption of 
the coronary flow for a period of 45 min. Coronary perfusion 
was then restored for 120 min. CaMKll inhibition was achieved 
by treating the hearts, 10 min before ischemia and during the 
first 10 min of reperfusion, with 2.5 pM of the CaMKll inhibitor 
KN-93 (KN). This concentration of KN produced a slight albeit 
significant decrease in basal contractility (12.9±3.9%, 77 = 12). 
At indicated times during the IZR protocol, hearts were either 
freeze-clamped and stored at -80 °C for biochemical assays or 
submitted to the procedures described below.
2.4. Infarct size
After the reperfusion period, hearts were perfused with 
1% triphenyltetrazolium chloride (TTC ) in phosphate buffer 
(pH 7.4) for 7 min and immersed in this solution for another 
7 min. The hearts were frozen at -20 °C for 1 h and then cut 
into six transverse slices (2 mm thick) along the long axis of 
the LV, from apex to base. Infarct areas were enhanced by 
storage in 10% formaldehyde solution for 48 h before 
measurement. The infarct area was calculated by computer 
planimetry (Scion Image, Scion Corp, USA) and expressed 
as a percentage of the total area of the heart [18].
2.5. LDH determination
Cardiac injury was assessed by measuring the level of the 
LDH released in the perfusion effluent of the first 10 min of 
reperfusion. LDH was assessed by an enzymatic method 
(Roche, Mannheim).
2.6. Terminal deoxynucléotidyl transferase-mediated dUTP 
nick-end (TUNEL) labeling
Myocardial slices obtained from the middle of the long axis 
of the LV were fixed in buffered formalin and processed for 
histological examination. TUNEL assay was performed in 
deparaffinized sections (5 pm thick) with an Apop Tag kit 
(Chemicon International) according with the supplier’s 
instructions. Stained sections counterstained with hematoxylin 
were capUired with a digital RGB video camera (Evolution VF, 
Qimaging, Canada) attached to a microscope (Olympus BX- 
50, Tokyo). Twenty areas at high magnification (objective 40* ) 
were randomly chosen in each stained section and approxi­
mately 500 myocytes were analyzed per section. Images were 
processed by a digital image analyzer program (Image-Pro 
Plus V6.O, Media Cybernetics Silver Spring, MA) and 
percentage of TUNEL-positive myocytes was calculated by 
two blinded independent investigators. Cardiac myocytes were 
identified following morphologic (nuclei with elliptical shape 
and striated cytoplasm) and morphometric parameters [19].
2.7. Myocyte isolation
Myocytes were isolated by enzymatic digestion and kept 
in a HEPES buffered solution at room temperature until 
used, as previously described [20]. Unless otherwise 
specified, experiments were performed at 37 °C.
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2.8. Simulated I/R
Myocytes were plated in HEPES buffered solution on 
35 mm cell culture dishes. Simulated ischemia was performed 
according to Louch et al. [21], with minor modifications. 
Ischemia (45 min) was reproduced by a buffer exchange to 
ischemia-mimetic solution (in mM: 123 NaCl, 20 HEPES, 
0.9NaH2PO4, 8 KC1,0.5 MgSO4,2.5 CaCl2 and20Na-lactate, 
gassed with 100% N2 and pH adjusted to 6.2 with NaOH). A 
100% N2 gas phase was layered over the experimental 
chamber during simulated ischemia. “Reperfusion” was 
initiated by returning to the initial HEPES buffered solution 
and removal of the N2 gas phase. Assessment of cell viability 
and apoptosis was performed after 60 min of reperfusion.
2.9. Assessment of cell viability and apoptosis
Cell viability was assessed by trypan blue exclusion 
assay. At the end of the simulated I/R protocol, 20 pl of 0.4% 
trypan blue was added to the culture dish. After - 5 min of 
equilibration, cells were counted under microscope. Cells 
were also classified as viable or nonviable according to their 
length-to-width ratio (>3 were considered viable [22]). 
Apoptosis was measured using the caspase-3 fluorescent 
substrate, Phiphilux (Oncolmmunin; Gaithersburg, MD). 
2.5 |iVl Phiphilux was added to each culture dish at the start 
of reoxygenation and allowed to incubate for 1 h at 37 °C. 
Myocytes were gently washed once and imaged under a 
fluorescence microscope.
2.10. Recombinant adenoviruses
Two first-generation type 5 recombinant adenovirus, were 
used. Ad.pgal carries the |’>-galactosidase and the green 
fluorescent protein (GFP) genes and Ad.CaMKII, carries 
both the CaMKIIôc and the GFP genes, each under separate 
cytomegalovirus promoters.
2.11. Culture and adenovirus infection of adult ventricular 
cardiomyocytes
After isolation, cells were resuspended in DMEM 
medium containing (g/1): 0.0176 ascorbic acid, 2 BSA, 0.4 
L-camitine, 0.66 creatine, 0.62 taurine, 50 U/ml penicillin 
and 50 U/ml streptomycin, and counted. Myocytes plated at 
a density of 5 x 104 cells/ml were infected with adenoviruses 
at a multiplicity of infection of 100 and cultured for 48 h. 
After this period, cells were used to verify transgene 
expression and virus transfection efficiency and for protocols 
of simulated I/R.
2.12. Transgene expression and virus transfection efficiency
Transgene expression was monitored by GFP fluores­
cence at an excitation wavelength of 480 nm. Virus 
transfection efficiency was verified by Western blotting.
2.13. Indo-1 fluorescence and cell shortening measurements
Isolated myocytes were loaded with Indo-l/AM (17 pM 
for 9 min) and Indo-1 fluorescence and cell shortening 
was determined as previously described [19,23]. Ratio of 
Indo-1 emission (410 and 490 nm) was taken as an index of
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Fig. 1. Increased phosphorylation of Tin'17 of PLN and mechanical recovery 
during reperfusion. A. Representative immunoblots showing the phosphor­
ylation of PLN sites (PSer16-PLN and PThr17-PLN) of hearts submitted to 
different times of reperfusion after the 45 min of ischemia and of non­
ischemic hearts perfused in the absence (Ctrl) and the presence of 30 nM 
isoproterenol (Iso), run in parallel and used as an internal positive control. A 
blot probed against PLN demonstrates equal protein loading at all the 
different times showed. Overall results of 3-11 hearts show that the 
phosphorylation of Thr17 of PLN increased at the onset of reperfusion, 
indicating an enhancement of CaMKII activity. n = 3 only correspond to time 
points greater that 60 min, whereas all other time points consist of at least 6 
experiments. PLN phosphorylation was expressed as percentage of Ser16 and 
Thr17 phosphorylation induced by Iso. #p<0.05 vs. Ctrl. B. Time course of 
maximal rate of rise of pressure development (+dP/ di) of hearts submitted 
to the I/R protocol, in the presence and absence of CaMKII inhibition 
(2.5 pM KN). Note the expanded ordinate scale between 0 and 250 mm Hg 
to better visualize the effect of KN during reperfusion. Results are average of 
4 hearts in each group. *p<0.05 vs. I/R in the absence of KN.
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the Caf . This group of experiments was run at room 
temperatine.
2.14. Sample preparation for Western blot
Homogenates, cytosolic fractions and SR membrane 
vesicles were prepared from the pulverized ventricular tissue 
of the perfused hearts [6,24,25] and whole-cell lysates were 
obtained from isolated myocytes [20]. Protein was measured 
by the method of Bradford using bovine serum albumin as 
standard.
2.15. Electrophoresis and Western blot analysis
Proteins from cardiac homogenates (80 pg, caspase-3), 
cytosolic fractions (30 pg, Bcl-2, Bax), SR membrane 
vesicles (15 pg, PLN) and cell lysates (80 pg, CaMKII,
actin) were separated on appropriate Laemmli SDS-poly- 
acrylamide gels (buffer: 25 mM Tris-HCl, 190 mM Glycine 
and 0.1% SDS) and transferred to PVDF membranes as 
previously described [6,24]. Blots were probed with 
antibodies raised against Ser16 or Thr17-phosphorylated 
PLN (Badrilla, Leeds), PLN (ABR), active-caspase-3, 
phospho-CaMKII (Chemicon International), Bcl-2, Bax 
(Santa Cruz Biotechnology) and actin (Sigma). Immunore­
activity was visualized by peroxidase-based chemilumines­
cence detection kit (Amersham Biosciences). The signal 
intensity of the bands in the immunoblots was quantified by 
densitometry using Image J software (NIH, USA).
2.16. Statistical analysis
Data are expressed as means±SEM. Unpaired or paired 
Student t test or ANO VA were used for statistical comparisons
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Fig. 2. CaMKII inhibition diminished I/R-induced infarct size, necrosis and apoptosis. A. Cross-sections of TTC staining in non-ischemic hearts (control) and 
hearts submitted to irreversible PR protocol in the absence (I/R) or presence of 2.5 pM KN (I/R+KN). The bar graph on the right depicts the overall results of 4 
independent experiments in each group. B. Lactate dehydrogenase (LDH) release during the first 10 min of reperfusion of control (n = 9), I/R (n = 10) and I/R+KN 
(« = 5) hearts. C. TUNEL staining in LV transverse sections obtained at the end of the I/R protocol in the absence or presence of KN. CaMKII inhibition reduced 
the number of TUNEL positive cells (brown nuclei with arrows). The calibration bar represents 10 pm. The bar graph shows pooled data from n = 3-7 experiments. 
D. Representative blots of active-caspase-3 and a-actin in control, I/R and I/R+KN hearts. The bar graph shows the overall data of «=4-5 experiments. E. 
Representative blots of Bcl-2/Bax protein expression determined in hearts subjected to I/R in the absence and presence of 2.5 pM KN. Similar results were 
obtained in 3 additional experiments. Data are expressed as mean+SEM, *p<0.05 vs. control; #p<0.05 vs. I/R.
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3. Results
3.1. Time course of the phosphorylation of PLN and the 
mechanical recovery during the irreversible 1/R injury
A Control
Fig. 1A shows the phosphorylation of PLN residues at 
different times during reperfusion after 45 min of global 
ischemia in perfused rat hearts. Phosphorylation of Ser16 of 
PLN was slightly increased at the beginning of reperfusion
reaching significant levels at 3 min. Thr17 phosphorylation 
was also increased at 3 min of reperfusion and then slowly 
decayed towards levels lower than controls. The increase in 
the phosphorylation of Thr17 site of PLN indicates an 
enhanced activity of CaMKII, triggered by the onset of 
reperfusion. Previous reports have demonstrated in rat and 
mouse hearts that this reperfusion-induced Thr17 phosphor­
ylation could be diminished by the CaMKII inhibitor, KN-93 
[6,8]. Fig. IB shows that contractile recovery during the 
reperfusion period was extremely depressed, in agreement 
with what has been already reported after long ischemic 
periods of global ischemia [26]. This modest recovery was 
0.8
C Tg 1 [iM
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4 sec 30 sec
Fig. 3. CaMKII inhibition prevents spontaneous oscillations in isolated myocytes. Simultaneous recordings of cell shortening and Ca2 in adult rat 
cadiomyocytes during a protocol of I/R. The tracings on the left show steady state contraction at 0.5 Hz in a control cell (A), and in cells treated either with KN 
(B) or Tg (C). During the ischemic period (middle tracings), unpaced control cells show sporadic spontaneous contractions which are absent in the KN and Tg 
treated cells. At the start of reperfusion (right tracings) control cells begin to beat profusely and asynchronously in association with large Ca2~ oscillations (inset). 
These spontaneous events are absent in KN and Tg treated cells. Returning electrical stimulation to 0.5 Hz after 60 min of reperfusion in KN-treated cells elicits 
typical contractile activity and Ca2 ’ transients (panel B, far right).
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almost doubled however, in the presence of CaMKII 
inhibition. Absolute values of + dP/dt previous to ischemia 
were 3191.88±215.52 mmHg/s innon-treated vs. 2839.97± 
220.35 mm Hg/s in KN-treated hearts.
3.2. CaMKII inhibition decreases myocardial infarct size 
and LDH release
Myocardial infarct size was determined after the I/R 
protocol in the presence and the absence of CaMKII inhi­
bition (2.5 pM KN) in perfused hearts. Fig. 2A shows repre­
sentative TTC stained myocardial slices and overall results of 
control, I/R and I/R+KN treated hearts. The inhibition of 
CaMKII greatly reduced the infarct size produced by I/R. The 
level of LDH release was also assessed to evaluate necrosis. 
Total LDH release was reduced by approximately 57% in 
hearts submitted to I/R in the presence of 2.5 pM KN, when 
compared with non-treated hearts (Fig. 2B). These findings 
indicate reduced necrosis in rat hearts perfused with the 
CaMKII inhibitor. Taken together the above results point to a 
deleterious effect of CaMKII in the irreversible I/R injury.
3.3. CaMKII inhibition attenuates I/R-induced apoptosis
To study whether CaMKII inhibition influences the 
degree of apoptosis evoked by I/R, TUNEL staining was 
performed in control and I/R hearts, in the absence and 
presence of KN. KN reduced ER-induced apoptosis as 
indicated by the reduction in the number of TUNEL positive 
nuclei (Fig. 2C ). Since activation of caspases is a critical step 
in apoptosis, caspase-3 activity was also determined in KN- 
treated and non-treated hearts subjected to the I/R protocol. 
Fig. 2D shows that KN significantly reduced caspase-3 
activity induced by ER. We also assessed the effect of KN on 
Bcl-2 and Bax protein expression (Fig. 2E). The presence of 
KN during I/R significantly increased the Bcl-2/Bax ratio 
with respect to ERhearts (3.13±0.51 vs. 1.73±0.19, >2 = 10).
3.4. I/R causes intracellular Ca~ oscillations in isolated 
myocytes
In isolated myocytes subjected to simulated I/R, we 
measured cell shortening and Ca2+ (Fig. 3 ). Prior to the ER 
protocol, myocytes responded to electrical stimulation 
(0.5 Hz) with the expected normal steady state contractions 
and showed only sporadic spontaneous contractions during 
the ischemic period, when stimulation was stopped. In 5 out 
of 6 myocytes studied, reperfusion evoked multiple and large 
spontaneous contractions and Ca2+ oscillations, that culmi­
nated in membrane rupture and cell death. These multiple 
spontaneous events were prevented by 1 pM KN (Fig. 3B). 
Furthermore, KN-treated cells presented contractile activity 
and Ca2 cycling when electrical stimulation was resumed at 
the end of the reperfusion period, indicating that cell viability 
was preserved. Spontaneous contractions were also absent 
during reperfusion in thapsigargin (Tg, Fig. 3 C) or tetracaine 
(not shown) treated cells, providing evidence that these 
events are driven by release of Ca2+ from an overloaded SR.
3.5. CaMKII-inhibition prevents cell death in isolated 
cardiac myocytes submitted to simulated I/R
The protective effect of CaMKII inhibition was tested in 
cultured myocytes submitted to a protocol of simulated I/R. 
Fig. 4 shows that after 160 min of incubation under normoxic 
conditions, approximately 80% of the cells show rod-shape 
morphology. Simulated I/R reduced the number of viable 
myocytes to 50% and treatment ofthe myocytes with 1 pM KN
Control
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Fig. 4. Inhibition of CaMKII, reverse NCX mode and SR, prevent cell death 
induced by simulated I/R. Transmitted images of control myocytes and 
myocytes submitted to a protocol of simulated PR, either in the absence (I/R) or 
the presence of inhibitors of CaMKII, 1 pM KN-93 (IR+KN) or 1 pM AIP (1/ 
R+AIP), of the inhibitor of the reverse mode NCX, 5 pM KBR (I/R+KBR) or 
inhibitors of SR function 1 pM Tg+1 pM Ry (I/R + Tg+Ry). The 
representative images clearly show that the simulated PR protocol produced 
a vast number of nonrod shaped/nonviable cells which were largely absent 
when simulated PR was induced after CaMKII inhibition, reverse mode NCX 
blockade or inhibiting SR function. The overall results of these experiments are 
shown in the bar graph bellow. Data are mean±SEM from 5 independent 
experiments using cells form 5 hearts.
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Fig. 5. Simulated I/R induces both necrosis and apoptosis in isolated 
myocytes. A: Representative bright field images showing that simulated 
ischemia induces necrosis, as evidenced by the increased number of trypan 
blue positive cells (arrows) B: Bright field images of representative 
myocytes under control, normoxic conditions (left) or after 45 min of 
ischemia and 120 min of reperfusion (right) and C: corresponding 
fluorescent images of the same myocytes as in B, demonstrating apoptotic 
caspase-3 activation.
prior and throughout the I/R protocol, prevented cell mortality. 
Similar results were obtained in the presence of 1 |i\1 of the 
more specific CaMKII inhibitory peptide, AIP. The results on 
this figure further show that I/R-induced cell death could also 
be prevented by inhibiting Ca2+ influx via the NCX using 
5 jlM KB-R7943 (KBR), a specific inhibitor of the reverse 
NCX mode, or by inhibiting SR function using 1 |i\1 
ryanodine (Ry) plus 1 |i\1 thapsigargin (Tg). Furthermore, 1/ 
R-induced cell mortality was also prevented by blocking 
ryanodine receptors with 1 mM tetracaine. Taken together, 
these results indicate that both the NCX and the SR are key 
components ofthe signaling pathway leading to cell death. The 
doses of the inhibitors used were selected based on their IC5o 
for their specific target proteins. These inhibitors did not affect 
cellular viability when applied alone under control conditions 
and during the entire duration of the I/R protocol. In control 
experiments, we found that KBR, KN and AIP, at the 
concentrations used, did not significantly affect basal contrac­
tility and Ca2+ transient kinetics, whereas Ry+Tg produced a 
significant decrease in basal contractility and amplitude of the 
Ca2+ transient and a slowing of Ca2+ transient decay. 
Tetracaine decreased contractility to barely perceptible levels.
3.6. Simulated I/R causes necrosis and apoptosis in isolated 
cardiac myocytes
In a separate group of experiments, we evaluated whether 
apoptosis was involved in myocyte death induced by 
simulated I/R. Fig. 5A shows that after the simulated I/R 
protocol, cell viability was largely reduced. Most cells died 
from necrosis, as it was clearly evidenced by the increase in 
trypan blue positive myocytes. However, as shown in panels B 
and C, apoptotic signaling was also induced by I/R in isolated
Pgal CaMKII
P-CaMKil
a-actin
— 50kDa
— 42 kDa
Pgal
Control
*#□
I/R
CaMKII
Fig. 6. Overexpression of CaMKII enhanced cell death in isolated myocytes 
submitted to simulated I/R. Fluorescent images of myocytes, 48 h after 
infection with Ad.CaMKII. 100% of the myocytes showed GFP fluores­
cence indicating the co-expression of CaMKII. The representative blots 
below, of phospho-CaMKII and a-actin confirm the overexpression of Ad. 
CaMKII vs. Ad. [3 gal infected cells. The transmitted images show that 
similar to the observation in fresh cells, I/R reduced cell viability in |3gal 
overexpressing cells to approximately 50% (I/R |3gal). In CaMKII 
overexpressing cells, the negative impact of I/R on cell viability was greatly 
enhanced as evidenced by the increased number of dead cells (I/R CaMKII). 
The bar graph below depicts the overall results of cell viability assessed at 
the end of the reperfusion period. Three different fields with an average of 30 
to 60 cells were counted from triplicate dishes for each experimental 
condition. Data are mean±SEM from 4 independent experiments from 4 
hearts. #p<0.05 vs. I/R [3 gal. *p<0.05 vs. control. 
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myocytes as indicated by the increase in caspase-3 activity 
detected using a fluorescent caspase-3 substrate (5±1% 
control vs. 21 ±3% I/R). These results indicated that the 
decreased viability of isolated myocytes after the simulated I/R 
protocol, was due at least in part, to apoptotic cell death.
3. 7. Overexpression of CaMKII enhances cardiac cell death 
in isolated myocytes submitted to simulated I/R
The participation of CaMKII in I/R-induced cell death 
was confirmed in experiments of isolated myocytes over­
expressing CaMKII (Fig. 6 ). After 48 h of incubation, 100% 
of rod-shaped myocytes, infected with either Ad. | ’>gal or Ad. 
CaMKII virus, presented a robust expression of the reporter 
gene GFP, visualized by fluorescence microscopy and of 
CaMKII protein expression as confirmed by Western 
blotting. Similar to the results obtained in fresh cells, 
simulated I/R reduced cell viability by 50% in myocytes 
overexpressing |’>gal. However, CaMKII overexpression 
rendered cells more susceptible to I/R injury, as indicated 
by the significantly larger number of dead cells. The bar 
graph bellow depicts the overall results of these experiments.
4. Discussion
Oui' results indicate that activation of CaMKII at the 
beginning of reperfusion has a deleterious effect in the 
irreversible I/R injury, participating in a cascade of events 
that lead to apoptosis and necrosis. To our knowledge, this is 
the first report demonstrating the protective effect of 
CaMKII inhibition against both necrosis and apoptosis, 
caused by irreversible I/R injury. This effect was indepen­
dent of the preparation and experimental protocol used, since 
it was observed in intact hearts submitted to global I/R and in 
isolated myocytes submitted to simulated I/R.
4.1. Role of the NCX
Previous studies from our and other laboratories indicate 
that the increase of Ca2+ influx which occurs at the 
beginning of reperfusion is mainly mediated by the reverse 
mode of the NCX [1,4,6,7]. The involvement of the NCX, 
both in forward and reverse modes, in the production of SR 
Ca2+ overload and apoptosis has been also previously 
reported [27,28]. The present results confirm these findings, 
since the deleterious effect of reperfusion was abolished in 
isolated myocytes by blocking the reverse NCX mode with 
the specific inhibitor KBR. Moreover, we previously showed 
that CaMKII-dependent phosphorylation of PLN at the onset 
of reperfusion, could be prevented by treating the perfused 
hearts with KBR. These findings indicate that Ca2+ influx via 
the NCX can induce CaMKII activation and PLN phosphor­
ylation [6]. The present results further suggest that Ca2+ 
influx via the reverse NCX mode could be the major source 
of Ca2+ for the activation of CaMKII in the setting of 
irreversible I/R.
4.2. Role of CaMKII
In the I/R hearts, CaMKII inhibition reduced infarct size 
in association with a significant recovery of contractility 
during reperfusion, with respect to the untreated hearts. 
Moreover, CaMKII inhibition reduced LDH release, cas- 
pase-3 activity and the number of TUNEL positive cells, and 
increased Bcl-2/Bax ratio, indicating that CaMKII inhibition 
prevents both necrosis and apoptosis. The protective role of 
CaMKII inhibition against necrosis was confirmed in 
isolated myocytes, where we observed a decrease in cell 
mortality after I/R, when cells were treated with either KN or 
the more specific CaMKII inhibitor, AIP. The deleterious 
role played by CaMKII in I/R was further supported by the 
evidence that CaMKII overexpression in isolated myocytes 
exacerbated cellular death. The fact that the protection 
introduced by CaMKII inhibition was obtained in isolated 
myocytes, using two different inhibitors that did not affect 
basal contractility or Ca2+ dynamics, would rule out the 
possibility of unspecific effects of the drugs used. Previous 
studies have shown CaMKII to be pro-apoptotic under 
conditions of enhanced |’> 1 -adrenergic stimulation, or 
enhanced Ca2+ influx through L-type Ca2+ channels 
[15,16]. Recent results by Yang et al. [14], using isolated 
ventricular myocytes from transgenic mice overexpressing a 
highly specific CaMKII inhibitory peptide, have further 
confirmed the apoptotic effects of this kinase in vivo during 
excessive catecholamine stimulation and its possible contri­
bution to left ventricular adverse remodeling. In this study, 
we extend the concept of the deleterious role of CaMKII to 
another pathophysiological situation, the irreversible ER 
injury. Furthermore, the results shown herein are the first to 
describe a role for CaMKII in necrotic cell death induced by 
ER in addition to its pro-apoptotic effect.
4.3. Role of the SR and mitochondria
Although our results do not reveal which is the target of 
CaMKII action, they do suggest a possible signalling 
cascade in which the SR and the mitochondria appear to 
be involved. The important role played by the SR and the 
release of Ca2+ through RyR2 in the modulation of apoptosis 
and necrosis during reperfusion is supported in the present 
work by two types of experimental evidence: 1) The protocol 
of simulated I/R in isolated myocytes produced large 
spontaneous contractions and Ca2+ oscillations upon reper­
fusion, typical of SR Ca2+ overload. These Ca2+ waves were 
absent after inhibition of SR Ca2+ uptake (Tg), SR Ca2+ 
release (tetracaine) or CaMKII (KN). These results indicates 
that the spontaneous contractions and Ca2+ oscillations are 
driven by the release of Ca2+ from an overloaded SR and 
furthermore, that they are dependent on CaMKII activity; 2) 
Blockade of SR Ca2+ uptake and release with Ry+Tg, 
reduced myocyte death. Collectively, our findings directly 
relate the increase in SR Ca2+ load and release with the 
production of CaMKII-dependent cell death. The involvement 
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of the SR in the apoptotic and necrotic pathways and the 
increased SR Ca2+-load as a fundamental step in triggering 
both death processes has been previously reported [4,29]. 
Indeed, experimental evidence linked the apoptotic effect of 
CaMKII, observed under conditions of enhanced Ca2+ 
influx through L-type Ca2+ channels, to an increased 
SERCA2a activity. These experiments suggested an 
apoptotic pathway in which the phosphorylation of Thr17 
site of PLN constitutes a key mechanism for SR Ca2+ 
overload, which would then lead to SR Ca2+ leak and 
mitochondrial Ca2+ uptake [16]. Although in our studies the 
phosphorylation of Thr17 was examined and used as “a 
marker” of CaMKII activation at the onset of reperfusion, 
the experimental evidence indicates that this phosphoryla­
tion might represent an important step in the series of events 
leading to SR Ca2+ overload. Indeed, both phenomena, 
phosphorylation of Thr17 and Ca2+ overload (6 and the 
present results), could be prevented by CaMKII inhibition. 
Our results also showed that CaMKII inhibition can prevent 
the decrease in the Bcl-2/Bax ratio and the significant 
increase in caspase-3 activity produced by I/R. Bax and/or 
Bak can translocate to mitochondria in the presence of 
apoptotic stimuli, like an increase in cytosolic Ca2+, and 
they oligomerize to form pores, allowing cytochrome c 
release and caspase-3 activation. This action is prevented 
by the antiapoptotic members of the Bcl-2 family, like Bcl-2 
and Bcl-xL [30]. Our results would then indicate the 
involvement of mitochondria in the signalling pathway 
leading to apoptosis, in addition to the role of the SR [30].
Taken together, the present findings suggest a cascade of 
events involving the reverse mode NCX, the SR and the 
mitochondria, where the activation of CaMKII plays a 
critical role in the signalling to apoptosis and necrosis. In this 
scenario, it is tempting to speculate that both apoptosis and 
necrosis induced by I/R share the same trigger i.e. SR Ca2+ 
overload and release, induced by CaMKII activation. Indeed, 
previous studies have shown that necrosis and apoptosis 
induced by I/R can share a common signalling pathway [31].
Overall, the present study shows that CaMKII inhibition 
can effectively protect against I/R-induced necrosis and 
apoptosis, highlighting the relevance of CaMKII inhibition 
as an important therapeutic tool, to be applied during 
reperfusion to reduce myocyte death by I/R injury. In addition, 
the present results, in conjunction with previous findings from 
our laboratory [6-8], indicate a dual role of C aMKII in the I/R. 
We have previously shown that CaMKII mediates a 
cardioprotective effect after a short period of ischemia 
(stunned heart), allowing an improved contractile response 
through the phosphorylation of the Thr17 site of PLN. In 
contrast, the present results demonstrate that CaMKII 
activation is detrimental in the irreversible I/R injury, inducing 
necrosis and apoptosis of cardiac myocytes. The reason for this 
dual effect is unknown although a similar dual action for 
CaMKII has been reported in other pathological conditions. 
Indeed, the activation of CaMKII during acute Bl-adrenergic 
stimulation has beneficial effects on heart function, since it 
mediates the positive inotropic and relaxant actions of these 
agents [24], while CaMKII activity becomes an apoptotic 
signal in sustained [31-adrenergic stimulation, [15]. Although 
speculative, our results suggest the possibility that the previous 
myocardial ischemic history of the heart determines the 
protective or detrimental action of this kinase.
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